Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients

Table 1

The association between the ZNF667-AS1 expression and different clinicopathological features of 155 human gliomas.

Parameter	No. of cases	ZNF667-AS1 expression		value
		High	Low
Age				0.369
<50	82	39	43
≥50	73	40	33
Gender				0.394
Male	93	50	43
Female	62	29	33
WHO grade				0.005
I-II	108	47	61
III-IV	47	32	15
KPS score				0.008
<80	57	37	20
≥80	98	42	56
Tumor size				0.145
<3 cm	95	44	51
≥3 cm	60	35	25